Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 13/20 | 0.39 |
| ▸ | HCRTR2 | O43614 | 13/20 | 0.39 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.37 |
| ▸ | SMO | Q99835 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4696558 | 0.86 | HCRTR1 (0.43) | HCRTR1HCRTR2KCNH2 | |
| SCHEMBL4696224 | 0.85 | HCRTR1 (0.39) | HCRTR1HCRTR2KCNH2 | |
| SCHEMBL4697075 | 0.85 | HCRTR1 (0.43) | HCRTR1HCRTR2KCNH2 | |
| SCHEMBL4697490 | 0.85 | HCRTR1 (0.44) | HCRTR1HCRTR2KCNH2 | |
| SCHEMBL4809142 | 0.84 | HCRTR1 (0.41) | HCRTR1HCRTR2KCNH2 | |
| SCHEMBL4698184 | 0.79 | HCRTR1 (0.46) | HCRTR1HCRTR2 | |
| SCHEMBL4968486 | 0.79 | HCRTR1 (0.42) | HCRTR1HCRTR2KCNH2 | |
| SCHEMBL4696118 | 0.79 | HCRTR1 (0.37) | HCRTR1HCRTR2 | |
| SCHEMBL5234333 | 0.79 | HCRTR1 (0.41) | HCRTR1HCRTR2 | |
| SCHEMBL4696692 | 0.78 | HCRTR1 (0.42) | HCRTR1HCRTR2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1987036-A1 | HETERO-BYCYCLIC ANTIVIRAL COMPOUNDS | F.HOFFMANN-LA ROCHE AG (CH) | 2008-11-05 | — | — | EP | claimed |
| WO-2007093520-A1 | HETERO-BYCYCLIC ANTIVIRAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-08-23 | — | — | WO | claimed |
| EP-1987036-A1 | HETERO-BYCYCLIC ANTIVIRAL COMPOUNDS | F.HOFFMANN-LA ROCHE AG (CH) | 2008-11-05 | — | — | EP | disclosed |
| WO-2007093520-A1 | HETERO-BYCYCLIC ANTIVIRAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-08-23 | — | — | WO | disclosed |